Chemoprevention in familial adenomatous polyposis.

doi:10.1016/j.bpg.2011.08.002

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Back to search

Article

Chemoprevention in familial adenomatous polyposis.

Best practice & research. Clinical gastroenterology - 1 Aug 2011

Kim Brian, Giardiello Francis M

Abstract excerpt

Familial adenomatous polyposis (FAP) predictably leads to adenomas and eventual adenocarcinomas in the lower gastrointestinal tract and less frequently, the upper gastrointestinal tract. Chemopreventive strategies have been studied in FAP patients to delay the development of adenomas in the upper and lower gastrointestinal tract, as well as to prevent recurrence of adenomas in the retained rectum of patients...

Topics

Adenomatous Polyposis Coli
Animals
Anticarcinogenic Agents
Chemoprevention
Colectomy
Colorectal Neoplasms
Disease Progression
Genetic Predisposition to Disease
Humans
Risk Assessment
Risk Factors
Treatment Outcome

Source

Open in PubMed Open full text

Identifiers

PMID: 22122775
DOI: 10.1016/j.bpg.2011.08.002
PMCID: PMC3569729

Genes

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 30 Aug 2026.

Community interpretation

Discuss the evidence

Ask a question, add context or challenge an interpretation. Community activity is separate from scientific evidence strength.

discussions

replies

Citations encouraged

Claims remain attributable.

No discussion yet

Be the first to add a careful, cited interpretation.

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics